CU-TZD-20
CU-TZD-20 is a PARP-1 inhibitor. CU-TZD-20 has a high affinity for binding to the PARP-1 catalytic domain and good structural stability. CU-TZD-20 competitively occupies NAD+ binding sites and forms stable interactions with key catalytic residues. CU-TZD-20 can be used for cancer research[1].
Product Specifications
UNSPSC
12352005
Target
PARP
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Field of Research
Cancer
Smiles
OC1=C2C(OC(C=C2)=O)=C(O)C(NC(C3NC(/C(S3)=C/C4=CC(O)=C(OC)C(O)=C4)=O)=O)=C1
Molecular Formula
C21H16N2O9S
Molecular Weight
472.42
References & Citations
[1]Rambabu P, et al. Energy Landscape Mapping–Guided Rational Design of Coumarin‐Based PARP‐1 Inhibitors[J]. ChemistrySelect, 2025, 10 (40) : e03552.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040040-100 1x 100 µL
CD35 / CR1 (E11), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880776-500 1x 500 µL
HER-2 / CD340 (ERB2/776), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401154-100 1x 100 µL
Mucin 3 (MUC3/1154), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041757-500 1x 500 µL
CELA3B / ELA3B (Pancreatic Function Marker) (CELA3B/1757), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 